[1] |
ANSELMO A, IARIA G, PELLICCIARO M, et al. Native nephrectomy in patients with autosomal dominant polycystic kidney disease evaluated for kidney transplantation[J]. Transplant Proc, 2019, 51(9): 2914-2916. DOI: 10.1016/j.transproceed.2019.08.010.
|
[2] |
CORNEC-LE GALL E, ALAM A, PERRONE RD. Autosomal dominant polycystic kidney disease[J]. Lancet, 2019, 393(10174): 919-935. DOI: 10.1016/S0140-6736(18)32782-X.
|
[3] |
BEVILACQUA M, GRADIN S, WILLIAMS J, et al. The BC ADPKD network: a comprehensive provincial approach to support specialized and locally delivered multidisciplinary ADPKD care[J]. Can J Kidney Health Dis, 2021, 8: 20543581211035218. DOI: 10.1177/20543581211035218.
|
[4] |
PEI Y, OBAJI J, DUPUIS A, et al. Unified criteria for ultrasonographic diagnosis of ADPKD[J]. J Am Soc Nephrol, 2009, 20(1): 205-212. DOI: 10.1681/ASN.2008050507.
|
[5] |
IRAZABAL MV, RANGEL LJ, BERGSTRALH EJ, et al. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials[J]. J Am Soc Nephrol, 2015, 26(1): 160-172. DOI: 10.1681/ASN.2013101138.
|
[6] |
AKBARI P, NASRI F, DENG SX, et al. Total kidney volume measurements in ADPKD by 3D and ellipsoid ultrasound in comparison with magnetic resonance imaging[J]. Clin J Am Soc Nephrol, 2022, 17(6): 827-834. DOI: 10.2215/CJN.14931121.
|
[7] |
RAJ S, SINGH RG, DAS P. Mutational screening of PKD1 and PKD2 in Indian ADPKD patients identified 95 genetic variants[J]. Mutat Res, 2020, 821: 111718. DOI: 10.1016/j.mrfmmm.2020.111718.
|
[8] |
HATEBOER N, V DIJK MA, BOGDANOVA N, et al. Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group[J]. Lancet, 1999, 353(9147): 103-107. DOI: 10.1016/s0140-6736(98)03495-3.
|
[9] |
MALLAWAARACHCHI AC, LUNDIE B, HORT Y, et al. Genomic diagnostics in polycystic kidney disease: an assessment of real-world use of whole-genome sequencing[J]. Eur J Hum Genet, 2021, 29(5): 760-770. DOI: 10.1038/s41431-020-00796-4.
|
[10] |
NIELSEN ML, LILDBALLE DL, RASMUSSEN M, et al. Clinical genetic diagnostics in Danish autosomal dominant polycystic kidney disease patients reveal possible founder variants[J]. Eur J Med Genet, 2021, 64(4): 104183. DOI: 10.1016/j.ejmg.2021.104183.
|
[11] |
CHAPMAN AB, DEVUYST O, ECKARDT KU, et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference[J]. Kidney Int, 2015, 88(1): 17-27. DOI: 10.1038/ki.2015.59.
|
[12] |
LUBENNIKOV AE, PETROVSKⅡ NV, KRUPINOV GE, et al. Bilateral nephrectomy in patients with autosomal dominant polycystic kidney disease and end-stage chronic renal failure[J]. Nephron, 2021, 145(2): 164-170. DOI: 10.1159/000513168.
|
[13] |
PIERRE M, MOREAU K, BRACONNIER A, et al. Unilateral nephrectomy versus renal arterial embolization and technique survival in peritoneal dialysis patients with autosomal dominant polycystic kidney disease[J]. Nephrol Dial Transplant, 2020, 35(2): 320-327. DOI: 10.1093/ndt/gfz200.
|
[14] |
ZHOU C, GU Y, MEI C, et al. Dialysis modality and mortality in polycystic kidney disease[J]. Hemodial Int, 2018, 22(4): 515-523. DOI: 10.1111/hdi.12673.
|
[15] |
DARIUS T, BERTONI S, DE MEYER M, et al. Simultaneous nephrectomy during kidney transplantation for polycystic kidney disease does not detrimentally impact comorbidity and graft survival[J]. World J Transplant, 2022, 12(5): 100-111. DOI: 10.5500/wjt.v12.i5.100.
|
[16] |
GADELKAREEM RA, ABDELGAWAD AM, MOHAMMED N. Simultaneous kidney transplantation and ipsilateral native nephrectomy in patients with autosomal dominant polycystic kidney disease[J]. World J Transplant, 2022, 12(9): 310-312. DOI: 10.5500/wjt.v12.i9.310.
|
[17] |
XU J, D'SOUZA K, LAU NS, et al. Staged versus concurrent native nephrectomy and renal transplantation in patients with autosomal dominant polycystic kidney disease: a systematic review[J]. Transplant Rev (Orlando), 2022, 36(1): 100652. DOI: 10.1016/j.trre.2021.100652.
|
[18] |
TSAI TY, CHEN CH, WU MJ, et al. Outcomes of kidney transplantation in patients with autosomal dominant polycystic kidney disease: our experience based on 35-years follow-up[J]. Diagnostics (Basel), 2022, 12(5): 1174. DOI: 10.3390/diagnostics12051174.
|
[19] |
PRUDHOMME T, BOISSIER R, HEVIA V, et al. Native nephrectomy and arterial embolization of native kidney in autosomal dominant polycystic kidney disease patients: indications, timing and postoperative outcomes. a systematic review[J]. Minerva Urol Nephrol, 2022, DOI: 10.23736/S2724-6051.22.04972-2[Epub ahead of print].
|
[20] |
HAN JH, JEONG SH, YUK HD, et al. Safety and feasibility of synchronous unilateral nephrectomy and contralateral heminephrectomy for extremely severe autosomal dominant polycystic kidney disease: techniques and outcome[J]. Investig Clin Urol, 2022, 63(3): 341-349. DOI: 10.4111/icu.20210461.
|
[21] |
JEAN RA, ALEXANDRE M, YOO PS. Kidney transplantation with and without native nephrectomy for polycystic kidney disease: results of the national inpatient sample and the rationale for a 2-staged procedure[J]. J Am Coll Surg, 2018, 226(6): 1079-1084. DOI: 10.1016/j.jamcollsurg.2017.11.021.
|
[22] |
PRABHU M, DAMLE NA, RAY A, et al. 18F-FDG PET/CT in cyst infection in autosomal dominant polycystic kidney disease[J]. Indian J Radiol Imaging, 2020, 30(1): 102-104. DOI: 10.4103/ijri.IJRI_469_18.
|
[23] |
常染色体显性多囊肾病临床实践指南专家委员会. 中国常染色体显性多囊肾病临床实践指南(第二版)[J]. 临床肾脏病杂志, 2019, 19(4): 227-235. DOI: 10.3969/j.issn.1671-2390.2019.04.001.Expert Committee on Clinical Practice Guidelines for Autosomal Dominant Polycystic Kidney Disease. Chinese clinical practice guide for autosomal dominant polycystic kidney disease[J]. J Clin Nephrol, 2019, 19(4): 227-235. DOI: 10.3969/j.issn.1671-2390.2019.04.001.
|
[24] |
张磊, 张健, 田野, 等. 后腹腔镜联合Gibson切口多囊肾切除一期同种异体肾移植术3例报道并文献复习[J]. 临床和实验医学杂志, 2017, 16(8): 747-749. DOI: 10.3969/j.issn.1671-4695.2017.08.007.ZHANG L, ZHANG J, TIAN Y, et al. Simultaneous retroperitoneoscopic nephrectomy and kidney transplantation using Gibson incision with autosomal dominant polycystic kidney disease: report of three cases and literature review[J]. J Clin Exp Med, 2017, 16(8): 747-749. DOI: 10.3969/j.issn.1671-4695.2017.08.007.
|
[25] |
TSUKAMOTO S, URATE S, YAMADA T, et al. Comparative efficacy of pharmacological treatments for adults with autosomal dominant polycystic kidney disease: a systematic review and network meta-analysis of randomized controlled trials[J]. Front Pharmacol, 2022, 13: 885457. DOI: 10.3389/fphar.2022.885457.
|
[26] |
QIAN Q, DU H, KING BF, et al. Sirolimus reduces polycystic liver volume in ADPKD patients[J]. J Am Soc Nephrol, 2008, 19(3): 631-638. DOI: 10.1681/ASN.2007050626.
|
[27] |
WU LZ, WENG YQ, LING YX, et al. A Web of Science-based scientometric analysis about mammalian target of rapamycin signaling pathway in kidney disease from 1986 to 2020[J]. Transl Androl Urol, 2021, 10(3): 1006-1017. DOI: 10.21037/tau-20-1469.
|
[28] |
中华医学会器官移植学分会. 器官移植免疫抑制剂临床应用技术规范(2019版)[J]. 器官移植, 2019, 10(3): 213-226. DOI: 10.3969/j.issn.1674-7445.2019.03.001.Branch of Organ Transplantation of Chinese Medical Association. Technical specifcation for clinical application of immunosuppressive agents in organ transplantation (2019 edition)[J]. Organ Transplant, 2019, 10(3): 213-226. DOI: 10.3969/j.issn.1674-7445.2019.03.001.
|
[29] |
JUNG Y, IRAZABAL MV, CHEBIB FT, et al. Volume regression of native polycystic kidneys after renal transplantation[J]. Nephrol Dial Transplant, 2016, 31(1): 73-79. DOI: 10.1093/ndt/gfv227.
|
[30] |
YAMAMOTO T, WATARAI Y, KOBAYASHI T, et al. Kidney volume changes in patients with autosomal dominant polycystic kidney disease after renal transplantation[J]. Transplantation, 2012, 93(8): 794-798. DOI: 10.1097/TP.0b013e318246f910.
|
[31] |
MAHAJAN S, NARAYANAN V, BHATIA V, et al. Anesthetic considerations for a patient with autosomal dominant polycystic kidney disease, having a ruptured intracranial aneurysm for endovascular coiling: a case report[J]. Asian J Neurosurg, 2022, 17(2): 379-382. DOI: 10.1055/s-0042-1750811.
|
[32] |
ECONIMO L, ZENI L, CORTINOVIS R, et al. ADPKD and intracranial aneurysms: indications for screening, follow-up and clinical management[J]. G Ital Nefrol, 2021, 38(5): 2021-vol5.
|